Simplifying Global Compliance
FDAnews Drug Daily Bulletin
EU Lifts Restrictions on UCB’s Neupro
June 30, 2009
Pharmaceutical group UCB said the European Commission has lifted restrictions on its Parkinson’s disease drug Neupro, and that its talks with U.S. regulators to once again market the drug there are ongoing.
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing